We are live on ! Find out more

Prestige Consumer Healthcare

PBH

Market cap $2.21B

46.72 USD

-0.90

1.89%

At close Updated Sep 15, 9:38 AM EDT

1 day

-1.89%

5 days

-5.67%

1 month

-6.63%

3 months

0.11%

6 months

-23.3%

Year to date

-23.69%

1 year

-25.81%

5 years

-13.13%

10 years

0.02%

About: Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Employees: 890

Healthcare Drug Manufacturers - Specialty & Generic

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 28%

Neutral 68%

Negative 4%

Zacks Investment Research

PBH or NEOG: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Neogen (NEOG). But which of these two stocks is more attractive to value investors?

PBH or NEOG: Which Is the Better Value Stock Right Now?

Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript

Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript

Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript

Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference

TARRYTOWN, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Ron Lombardi, Chairman, President, & CEO and Christine Sacco, CFO and COO will participate in a fireside chat at the Barclays Global Consumer Conference on Thursday, September 10, 2026 at 12:45 p.m.

Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference

Zacks Investment Research

Is This the Right Time to Add PBH Stock to Your Portfolio?

Prestige Consumer Healthcare gains from acquisitions, e-commerce growth and strong cash flow, though currency swings and high debt remain key risks.

Is This the Right Time to Add PBH Stock to Your Portfolio?

Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress Test

National survey commissioned by DenTek, the #1 OTC dental guard brand for nighttime teeth grinding, finds nearly 8 in 10 football fans keep thinking about the game after it ends, with many reporting stress-related behaviors that extend into bedtime. NFL legends Ronde & Tiki Barber join DenTek to encourage fans to recognize when football stress may be affecting more than just game day.

Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress Test

Zacks Investment Research

PBH vs. SYK: Which Stock Is the Better Value Option?

Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?

PBH vs. SYK: Which Stock Is the Better Value Option?

Zacks Investment Research

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Prestige Consumer Healthcare (PBH) is a Strong Value Stock

Zacks Investment Research

PBH or SYK: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?

PBH or SYK: Which Is the Better Value Stock Right Now?

Premium Brands Q2 Earnings Call Highlights

Premium Brands TSE: PBH said its revised 2026 outlook reflects timing shifts in U.S. customer programs and the exit of a low-margin Ontario facility, rather than a deterioration in the company's underlying operating assumptions.

Premium Brands Q2 Earnings Call Highlights

Prestige Consumer Healthcare Q1 Earnings Call Highlights

Prestige Consumer Healthcare NYSE: PBH reported first-quarter fiscal 2027 revenue growth of 6.5%, supported by broad-based category strength, the initial contribution from its Breathe Right acquisition and retailer order timing. The company raised its reported full-year outlook to incorporate Breathe Right and LaCorium Health while maintaining its prior outlook for organic revenue growth.

Prestige Consumer Healthcare Q1 Earnings Call Highlights

See News Rankings

Price charts implemented using Lightweight Charts™